Widely prescribed anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body, according to a new study. Scientists found that JAK inhibitors, medications used to treat rheumatoid arthritis and other inflammatory conditions, can weaken a key immune defense against influenza, COVID-19 and other infections.
The researchers found that these drugs work by suppressing genes that normally help the body combat viruses. When those genes are turned down, the immune system's response to invading pathogens can be blunted, potentially leaving patients more vulnerable to infection. The finding points to an unexpected side effect of a drug class that has become an important tool in managing chronic inflammatory disease.
The discovery matters because JAK inhibitors are part of the treatment toolkit for many people living with long-term inflammatory illness. The drugs target signaling pathways that drive inflammation, which is why they are effective in these conditions. The new findings suggest that the same pathways also play a role in the body's antiviral defenses, creating a trade-off that clinicians and patients may need to weigh when deciding on therapy.
The study also highlights how drugs designed for one purpose can have effects that reach into other areas of physiology. The viruses named in the research, including influenza and the virus that causes COVID-19, affect large numbers of people every year. Understanding how these medications alter antiviral gene activity could help doctors anticipate which patients face greater risk and how to manage that risk during periods of high viral circulation.
The results leave several questions open for future work. Scientists will need to determine how strongly the effect appears in patients, how it varies between individual JAK inhibitors, and whether it changes the course of infection or the severity of illness. Such research would clarify whether the observed gene suppression translates into meaningful clinical harm, and whether monitoring or other precautions could reduce that risk without compromising treatment of the underlying disease.
16
